Skip to main content


Firm News

Mayer Brown represents Fresenius Kabi on agreement to acquire Fenwal

23 July 2012
Mayer Brown announced today that it advised Fresenius Kabi, a leading provider of infusion therapy and clinical nutrition, on its definitive agreement to acquire Fenwal Holdings, Inc., a global leader specializing in separation technologies for blood and cell collection and therapy with operations throughout North America, Latin America, Europe and Asia. The acquisition is expected to close by the end of the year. Financial terms of the agreement were not disclosed.

The Mayer Brown team included: Corporate & Securities – partners David Carpenter (New York), John Boelter (Chicago) and Christof Gaudig (Düsseldorf) and associates Michael Torres, Jen Rhein (Chicago) and Jan Streer (Düsseldorf), and registered foreign lawyer Edward Leung (Hong Kong); IP – partner Joseph Mahoney and associate Jonathan Kim (Chicago); and Tax Transactions & Consulting – partner Lee Morlock (Chicago).

Related Information

  • Related People
    Joseph A. Mahoney
    T +1 704 444 3654
    Dr. Jan Streer, LLM
    T +49 211 86224 242
    John P. Boelter
    T +1 212 506 2319
    Isabelle van Sambeck, LLM
    T +49 211 86224 112
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.